The bowel function index: A new validated scale for assessing opioid-induced constipation

Current Medical Research and Opinion

Volumn 28, Issue 3, 2012, Pages 457-466

  Ducrotté, Philippe ^a   Caussé, Christian ^b  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b Mundipharma SAS   (France)

Author keywords

Bowel Function Index; Constipation; Opioid induced constipation; Validation study

Indexed keywords

NALOXONE; NARCOTIC ANALGESIC AGENT; OXYCODONE; PLACEBO;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; BLOATING; BOWEL FUNCTION INDEX; CLINICAL FEATURE; CLINICAL RESEARCH; CONSTIPATION; DECREASED APPETITE; DIGESTIVE TRACT PARAMETERS; FATIGUE; FOOD REGURGITATION; HEARTBURN; HUMAN; INSOMNIA; INTESTINE FUNCTION; NAUSEA; OPIOID INDUCED CONSTIPATION; POPULATION RESEARCH; REVIEW; SCORING SYSTEM; TEST RETEST RELIABILITY; VALIDATION STUDY;

ANALGESICS, OPIOID; CONSTIPATION; DEFECATION; HUMANS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 84858256463     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2012.657301     Document Type: Review

References (41)

1. Holzer P, Ahmedzai SH, Neiderle N, et al. Opioid-induced bowel dysfunction in cancer-related pain: Causes, consequences, and a novel approach for its management. J Opioid Manag 2009;5:145-51
2. Bell TJ, Panchal SJ, Miaskowski C, et al. The prevalence, severity, and impact of opioid-induced bowel dysfunction: Results of a US and European Patient Survey (PROBE 1). Pain Med 2009;10:35-42
3. Bell T, Annunziata K, Leslie JB, et al. Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: Findings from the National Health and Wellness Survey. J Opioid Manag 2009;5:137-44
4. Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg 2001;182:11S-18S
5. Simpson K, Leyendecker P, Hopp M, et al. Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain. Curr Med Res Opin 2008;24:3503-12
6. Vondrackova D, Leyendecker P, Meissner W, et al. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain. J Pain 2008;9:1144-54
7. Meissner W, Leyendecker P, Mueller-Lissner S, et al. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation. Eur J Pain 2009;13:56-64
8. Schutter U, Grunert S, Meyer C, et al. Innovative pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: A large observational study under conditions of daily practice. Curr Med Res Opin 2010;26:1377-87
9. Panchal SJ, Müller-Schwefe P, Wurzelmann JI. Opioid-induced bowel dysfunction: Prevalence, pathophysiology and burden. Int J Clin Pract 2007; 61:1181-7
10. World Gastroenterology Organisation practice guidelines: Constipation. World Gastroenterology Organisation 2007. Available at: Http://www.omge.org/ assets/downloads/en/pdf/guidelines/05-constipation.pdf [Last accessed 26 January 2011]
11. Rentz AM, Yu R, Müller-Lissner S, et al. Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation. J Med Econ 2009;12:371-83
12. Eypasch E, Williams JI, Wood-Dauphinee S, et al. Gastrointestinal Quality of Life Index: Development, validation and application of a new instrument. Br J Surg 1995;82:216-22
13. Griffenberg L, Morris M, Atkinson N, et al. The effect of dietary fiber on bowel function following radical hysterectomy: A randomized trial. Gynecol Oncol 1997;66:417-24
14. Bennett M, Cresswell H. Factors influencing constipation in advanced cancer patients: A prospective study of opioid dose, dantron dose and physical functioning. Palliat Med 2003;17:418-22
15. Fallon MT, Hanks GW. Morphine, constipation and performance status in advanced cancer patients. Palliat Med 1999;13:159-60
16. Tuteja AK, Biskupiak J, Stoddard GJ, et al. Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain. Neurogastroenterol Motil 2010;22:424-30
17. Talley NJ, Phillips SF, Wiltgen CM, et al. Assessment of functional gastrointestinal disease: The bowel disease questionnaire. Mayo Clin Proc 1990; 65:1456-79
18. Pamuk ON, Pamuk GE, Celik AF. Revalidation of description of constipation in terms of recall bias and visual scale analog questionnaire. J Gastroenterol Hepatol 2003;18:1417-22
19. Knowles CH, Eccersley AJ, Scott SM, et al. Linear discriminant analysis of symptoms in patients with chronic constipation: Validation of a new scoring system (KESS). Dis Colon Rectum 2000;43:1419-26
20. Szeinbach SL, Baran RW, Bratten J, et al. Psychometric development and validation of the chronic constipation treatment satisfaction questionnaire (CTSAT-Q). Value Health 2009;12:1004-10
21. McMillan SC, Williams FA. Validity and reliability of the Constipation Assessment Scale. Cancer Nurs 1989;12:183-8
22. Slappendel R, Simpson K, Dubois D, et al. Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain. Eur J Pain 2006;10:209-17
23. Coffin B, CausséC. Constipation assessment scales in adults: A literature review including the new Bowel Function Index. Expert Rev Gastroenterol Hepatol 2011;5:601-13
24. Eypasch E, Williams JI, Wood-Dauphinee S, et al. Gastrointestinal Quality of Life Index: Development, validation and application of a new instrument. Br J Surg 1995;82:216-22
25. McCrea GL, Miaskowski C, Stotts NA, et al. Pathophysiology of constipation in the older adult. World J Gastroenterol. 2008;14:2631-8
26. Piche T, Dapoigny M, Bouteloup C, et al. [Recommendations for the clinical management and treatment of chronic constipation in adults.]. Gastroenterol Clin Biol 2007;31:125-35
27. Rentz AM, van Hanswijck de Jonge P, Leyendecker P, et al. Observational, nonintervention, multicenter study for validation of the Bowel Function Index for constipation in European countries. Curr Med Res Opin 2011;27:35-44
28. Ueberall MA, Muller-Lissner S, Buschmann-Kramm C, et al. The Bowel Function Index for evaluating constipation in pain patients: Definition of a reference range for a non-constipated population of pain patients. J Int Med Res 2011;39:9
29. Frank L, Kleinman L, Farup C, et al. Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol 1999;34:870-7
30. Veldhuyzen van Zanten SJ, Talley NJ, Bytzer P, et al. Design of treatment trials for functional gastrointestinal disorders. Gut 1999;45(Suppl 2):II69-77
31. Harari D, Gurwitz JH, Avorn J, et al. How do older persons define constipation? Implications for therapeutic management. J Gen Intern Med 1997;12:63-6
32. Rome Foundation. Guidelines - Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. J Gastrointestin Liver Dis 2006;15:307-12
33. Béziaud N, Laval G. Recommandations pour la prévention et le traitement de la constipation induite par les opioïdes chez le patient relevant de soins palliatifs. Med Pal 2009;8:S5-S34
34. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Control Clin Trials 1991;12:142S-58S
35. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in healthrelated quality of life: The remarkable universality of half a standard deviation. Med Care 2003;41:582-92
36. Wyrwich KW, Nienaber NA, Tierney WM, et al. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care 1999;37:469-78
37. Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 1999;52: 861-73
38. Guidance for industry. Patient-reported outcome measures: Use in medical product development to support labeling claims. US Food and Drug Administration 2009. Available at: Http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf [Last accessed 6 September 2011]
39. Camilleri M, Rothman M, Ho KF, et al. Validation of a bowel function diary for assessing opioid-induced constipation. Am J Gastroenterol 2011; 106:497-506
40. Svendsen K, Moroz A, Fredheim OM, et al. Longitudinal study of new noncancer users of prescribed strong opioids. Abstract PM045. Presented at the 13th World Conference on Pain - International Association for the Study of Pain; 30 August 2010; Montreal, Canada
41. Abramowitz L, Perrot S, Labreze L, et al. Constipation and bowel dysfunction induced by opioids patients with cancer pain: Prevalence, impact and assessment of bowel dysfunction using the Bowel Function Index score: Results of Dyonisos cohort. Abstract PM050. Presented at the 13th World Conference on Pain - International Association for the Study of Pain; 30 August 2010; Montreal, Canada